what they said (Hover the mouse cursor over underlined words for more info)
A new vaccine for shingles, a painful infection caused by the chickenpox virus, has been approved in the U.S., health officials said Friday.
Merck & Co. Inc., manufacturer of the vaccine Zostavax, said the U.S. Food and Drug Administration gave its approval late Thursday.
The vaccine is intended only for adults 60 years of age and older who previously have had chickenpox...
The original article can found in the Media Doctor archives.
what we said (Hover the mouse cursor over underlined words for more info)
This short story is good in describing shingles disease, its cause, prevalence and side effects; however does not tell anything about the source and type of the evidences which support this new vaccine, its possible side effects, its cost and availability in Canada, also available comparative alternatives for prevention and treatment of the disease.